Securing Medication Use in Pediatric Oncology Units in French-Speaking Africa: MAEva Pilot Program Results in Ivory Coast
The adaptation and implementation of the MAEva tool significantly reduced overall risk levels across all processes, demonstrating the effectiveness of the action plan and the tool's applicability in an African context. MAEva's proactive risk assessment approach proved effective and feasible without substantial financial investment.
Authors
- Guy Constant Yao
- Innocent Krasse
- Max N’doumy
- Line Couitchéré (ORCID: https://orcid.org/0000-0003-3246-5550)
- Charles Akoun
- Ngoma Robert
- Carole Coze (ORCID: https://orcid.org/0000-0003-3996-3835)
- Bertrand Pourroy (ORCID: https://orcid.org/0000-0002-2388-3518)
- Mu‐lin Yao
- Léa Zaho
- Olga Molly
Institutions
- Aix-Marseille Université (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- University Hospital Medical Center at Treichville (CI)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1200/go-24-00360
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.22